May 25, 2018
Rose
Boston-based health outcomes and tech company OM1 has just announced that it raked in $21 million in a Series B financing round led by Polaris Partners with participation from existing investors including General Catalyst and 7wire Ventures. This brings the company’s total financing to $36 million, according to Crunchbase.
from MobiHealthNews https://ift.tt/2s7mhQy
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment